Trial Information
Artificial Endometrial Preparation for Frozen Thawed Embryo Transfer Applying Either Endometrin or Utrogestan - a Clinical Comparative Study
Inclusion Criteria:
1. Patients undergoing frozen thawed ET cycles
2. Patient has at least two embryos suitable for transfer after thawing
3. Age 18-35 years -
Exclusion Criteria:
1. Any known sensitivity to Endometrin or Utrogestan
2. Endometrial thickness less than 7.5 mm after estrogen priming -
Type of Study:
Interventional
Study Design:
Allocation: Randomized, Endpoint Classification: Efficacy Study, Intervention Model: Parallel Assignment, Masking: Open Label, Primary Purpose: Treatment
Outcome Measure:
Pregnancy rates
Principal Investigator
Alex Simon
Investigator Role:
Principal Investigator
Investigator Affiliation:
Hadassah University Hospital
Authority:
Israel: Israeli Health Ministry Pharmaceutical Administration
Study ID:
EndoUtro-HMO-CTIL
NCT ID:
NCT00345306
Start Date:
March 2007
Completion Date:
Related Keywords:
- Frozen Thawed Embryo Transfer
- endometrial preparation
- Utrogestan
- Endometrin
- Adenoma